Week 7 Flashcards
environmental history
Activities community household hobbies occupation oral behaviors
Why are fetus/children most vulnerable?
toxins cross placenta rapid state of growht/development different absorption, metabolism unique habits/eat and drink, breathe faster longer life span
Restrictive lung disease
reduction in TLC on PFTS from Lung disease that result in decreased compliance (decreased volumes) and extra pulmonary restriction limiting ability to generate negative pleural pressure
Restriction due to lung disease
Lower compliant lungs (at any given pressure, lung volume will be less)
less compliant chest wall (any given pressure, lung volume less)
weakness (lower maximal inspiratory pressure-going to have a lower TLC)
Restrictive lung disease PFTS CW
lower TLC, lower RV, normal/low DLCO (lungs are fine)
Restrictive lung disease lung parenchyma
lower TLC, lower RV, super low DLCO
Restrictive lung disease muscle weakness
lower TLC, higher RV (hard to blow air out), normal DLCO
Extrapulmonary causes of restrictive lung disease
Chest wall (obesity), pleural disease, neuromuscular weakness
Pulmonary causes of restrictive lung disease
Pulmonary edema, cardiogenic edema, pneumonia, lung injury/inflammation, ILD
Pneumonia
infection in pulmonary parenchyma–initiates inflammatory response
Pneumonia histology
- alveolar lumens filled with neutrophils and macrophages
- congested capillaries
- thickened alveolar walls
Pneumonia causes
lower compliance lung from loss of aerated lung (exudate), atelectatic units, flood alveolar units (less participation in ventilation
Lung inflammation causes
- autoimmune (lupus, scleroderma, rheumatoid arthritis)
- injury (aspiration, noxious inhalation, trauma)
- meds (methotrexate, blemycin, nitrofurantoin, amiodarone)
- hypersensitivity pneumonitis
Lung inflammation results in
- widened alveolar septa
- increased elastic recoil forces (compliance decreases)
- increased work of breathing
- loss of alveolar/capillary units (obliterate capillary)
- hypoxemia
Cardiogenic pulmonary edema pathophysiology (Restrictive lung disease)
Rising capillary hydrostatic forces cause:
- increase in interestitial edema
- overwhelm lymphatic drainage
- development of alveolar edema
**fluid is transudative (low protein, low cells)
Cardiogenic pulmonary edema results in
- decreased compliance (interstitial water, flood alveolar units-no ventilation similar to pneumonia)
- hypoxemia
- activation of alveolar stretch receptors (J)-respond to increased interstitial fluid and stimulate ventilation (RR)
ARDS (pulmonary edema due to damage to alveolar capillary membrane)
low pressure pulmonary edema-acute respiratory failure
- injury and disruption of membrane
- alveolar flooding with protein rich exudate
- severe hypoxemia
- reduced lung compliance
Berlin definition ARDS
acute: within one week of known clinical insult
bilateral pulmonary infiltrates on CXR/CT
non cardiac reasons
hypoxemia P:F <300
P:F ratio
ratio of PaO2 to FiO2, lower means worse oxygenation
ARDS pathophysiology (acute)
initial injury to capillary endothelium/and or alveolar epithelium–leak alveolar capillary units and elaboration of protein rich cell rich exudates into alveolar space. Results in intense inflammatory reaction and deactivation of surfactant
ARDS and Diffuse alveolar damage DAD
- alveolar septal thickening (edema and inflammation)
- hyaline membranes (proteinacious deposits in alveolar spaces, results from fibrin rich exudative fluid and necrotic epithelial cells )
- Type II cell hyperplasia to attempt repair
Hypoxemia in ARDS
low PaO2
higher PAO2–leads to large Aa gradient
slight respiratory alkalosis (low PCO2, high pH) due to stimulation of ventilation from J receptors
Acute hypoxemia respiratory failure AHRF in ARDS
airspace flooding (edema, pus, blood in alveoli) intrapulmonary shunt physiology-refractory to oxygen supplementation
ARDS causes
- decreased lung compliance from flood and collapsed alveolar units 9surfactant dysfunction)
- interstitial edema/inflammation
- difficulty inflating/ventilating, loss of ventilated alveoli leads to over dissension and barotrauma
ARDS pathophysiology chronic
- fibroproliferative phase: fibroblast proliferation and collagen deposition (scarring), Type II epithelial cell proliferation for repair, iniate resorption of exudate
Survivors: full reepitheliazation, endothelial restoration, resolution of scar formation (over months)
ARDS management
supportive care
lung protective ventilator strategy (low tidal volumes, permissive hypercapnia, limit alveolar distending pressure <30 cm H20, non toxic FiO2
Interstitial lung disease
disorders predominately affecting the interstitial space of the lung
primarily affects the lung parenchyma (alveolar/capillary units) with inflammation, fibrosis, architectural distortion
Common pathophysiology of ILDs
- accumulation of inflammation and connective tissue in alveolar interstitial spaces of lung which causes
increased elastic recoil (low TLC, FRC ,RV)
destruction of alveolar/capillary gas surfaces (low DLCO and high Aa gradient)
thickening of alveolar capillary interface (diffusion limitation and exercise induced hypoxemia
Clinical findings in ILDs
dyspnea on exertion fatigue non productive paroxysmal cough abnormal breath sounds (inspiratory crackles) abnormal CXR CT (interstitial opacities) hypoxemia
ILDs Idiopathic pulmonary fibrosis
most common form of idiopathic interstitial pneumonia
Idiopathic pulmonary fibrosis pathophysiology
- induction of lung injury
- tissue injury and response (inflammation)
- abnormal wound healing
- parenchymal fibrosis and architectural distortion
leads to decreased SA, VQ mismatch, hypoxemia, and breathlessness
Clubbing
seen in IPF, asbestosis, lung cancer, CF, less common in COPD
due to growth factors such as VEGf, PDGF
IPF diagnosis
usually 50+ age
- exclude other causes (drug, environment, collage vascular disease)
- exam shows inspiratory crackles and clubbed digits
- UIP radiographic patern
- PFTs show restriction, reduction in DLCO
- surgical biopsy shows UIP
Usual Interstitial Pneumonia
irregular reticular lines (diffuse)
sub pleural, posterior, lower lobe predominance
sub pleural honeycombing
interlobular septa thickened by scarring
some normal areas of lung (heterogeneity)
loss of normal lung architecture/distortion
Acute exacerbation of IPF
acute SOB, new radiographic infiltrate, worsening gas exchange and no evidence of other causes (infection, HF, thromboembolism pneumothorax)
Disease course is variable in IPF
some people have faster progression than others, some have more exacerbations etc
IPF management
pirfenidone and nintedanib (inhibit fibrogenic pathways)
pulmonary rehab
supplemental O2
lung transplant for eligible patients
Pneumoconioses
accumulation of dust in lungs and the tissue reactions to its presence
results in nodular fibrosis and diffuse fibrosis
Abestos exposure
plumbing, sheet metal, shipbuilding, dockworkers, remodeling/demolition, mining, soils
Abestos related thoracic disease
Pleural disease: pleural plaques, benign asbestos pleural effusion, rounded atelectasis
malignant mesothelioma bronchogenic carcinoma (asbestosis and smoking)
Abestosis pathophysiolgy
fibers are persistent and active-can lead to oxygen free radicals which injury tissue and slowly leads to fibrosis
long latency >20 years
Abestosis diagnosis
reliable history (exposure and latency) evidence of interstitial lung fibrosis (crackles, clubbing, certified B reader for CT/CXR) absence of other causes
Abestosis Chest CT
peripheral and basilar intersititial fibrosis and honeycombing (like UIP)
ferruginous bodies
asbestos coated fiber with iron, engulfed by macrophage, but they are rare, not required for dx
Benigng abestos pleural effusion BAPE
one of the first things to occur-short latency, not a precursor for mesothelioma. often bloody and eosinophilic, typically resolves
hyaline pleura plaques
most common CXR abnormality
usually asymptomatic
discrete areas of fibrosis/thickening of parietal pleura
rounded atelectasis secondary to pleural adhesions
usually asymptomatic comet tail sign on chest CT
Malignant mesothelioma
rare tumor from pleural or parietal mesothelium forming a mass or rind with associated effusion, not related to tobacco use. poor prognosis (6-18 mo)
Primary lung cancer
abestosis and smoking-need to quit smoking
Silicosis
inhaled and poorly cleared from UPPER lung zones
chronic-upper lung nodules and mediastinal lymph nodes (egg shell calcifications)